YSP Southeast Asia Holding Bhd (KLSE:7178) — Market Cap & Net Worth
Market Cap & Net Worth: YSP Southeast Asia Holding Bhd (7178)
YSP Southeast Asia Holding Bhd (KLSE:7178) has a market capitalization of $72.29 Million (RM287.95 Million) as of July 23, 2026. Listed on the KLSE stock exchange, this Malaysia-based company holds position #20459 globally and #392 in its home market, demonstrating a -2.40% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying YSP Southeast Asia Holding Bhd's stock price RM2.03 by its total outstanding shares 141844985 (141.84 Million). See YSP Southeast Asia Holding Bhd (7178) reinvestment ratio to understand how much of operating cash flow is reinvested back into capital assets.
YSP Southeast Asia Holding Bhd Market Cap History: 2015 to 2026
YSP Southeast Asia Holding Bhd's market capitalization history from 2015 to 2026. Data shows growth from $70.66 Million to $72.29 Million (0.52% CAGR).
YSP Southeast Asia Holding Bhd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how YSP Southeast Asia Holding Bhd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.20x
YSP Southeast Asia Holding Bhd's market cap is 0.20 times its annual revenue
Latest Price to Earnings (P/E) Ratio
2.97x
YSP Southeast Asia Holding Bhd's market cap is 2.97 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $55.99 Million | $237.06 Million | $27.59 Million | 0.24x | 2.03x |
| 2017 | $79.28 Million | $261.56 Million | $20.38 Million | 0.30x | 3.89x |
| 2018 | $83.31 Million | $288.76 Million | $30.35 Million | 0.29x | 2.75x |
| 2019 | $72.55 Million | $295.62 Million | $23.01 Million | 0.25x | 3.15x |
| 2020 | $72.97 Million | $297.06 Million | $21.98 Million | 0.25x | 3.32x |
| 2021 | $63.86 Million | $281.86 Million | $15.18 Million | 0.23x | 4.21x |
| 2022 | $87.45 Million | $334.25 Million | $34.47 Million | 0.26x | 2.54x |
| 2023 | $79.67 Million | $355.00 Million | $37.31 Million | 0.22x | 2.14x |
| 2024 | $81.91 Million | $368.66 Million | $26.69 Million | 0.22x | 3.07x |
| 2025 | $74.43 Million | $365.12 Million | $25.03 Million | 0.20x | 2.97x |
Competitor Companies of 7178 by Market Capitalization
Companies near YSP Southeast Asia Holding Bhd in the global market cap rankings as of July 23, 2026.
Key companies related to YSP Southeast Asia Holding Bhd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #508 globally with a market cap of $52.60 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #521 globally with a market cap of $51.70 Billion USD ( CN¥353.33 Billion CNY).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #549 globally with a market cap of $48.78 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #622 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #508 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #521 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $51.70 Billion | CN¥55.39 |
| #549 | GALDERMA GROUP AG | NYSE:GALDY | $48.78 Billion | $42.53 |
| #622 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €14.90 |
YSP Southeast Asia Holding Bhd Historical Marketcap From 2015 to 2026
Between 2015 and today, YSP Southeast Asia Holding Bhd's market cap moved from $70.66 Million to $ 72.29 Million, with a yearly change of 0.52%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | RM72.29 Million | -2.87% |
| 2025 | RM74.43 Million | -9.13% |
| 2024 | RM81.91 Million | +2.81% |
| 2023 | RM79.67 Million | -8.89% |
| 2022 | RM87.45 Million | +36.94% |
| 2021 | RM63.86 Million | -12.48% |
| 2020 | RM72.97 Million | +0.58% |
| 2019 | RM72.55 Million | -12.92% |
| 2018 | RM83.31 Million | +5.08% |
| 2017 | RM79.28 Million | +41.60% |
| 2016 | RM55.99 Million | -20.76% |
| 2015 | RM70.66 Million | -- |
End of Day Market Cap According to Different Sources
On Jul 23rd, 2026 the market cap of YSP Southeast Asia Holding Bhd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $72.29 Million USD |
| MoneyControl | $72.29 Million USD |
| MarketWatch | $72.29 Million USD |
| marketcap.company | $72.29 Million USD |
| Reuters | $72.29 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About YSP Southeast Asia Holding Bhd
Y.S.P. Southeast Asia Holding Berhad, together with its subsidiaries, engages in the manufacturing and trading of generic drugs in Malaysia, Singapore, Vietnam, Philippines, Cambodia, Myanmar, Brunei, Indonesia, Thailand, Africa, and internationally. It operates through three segments: Manufacturing, Trading, and Investment Holding. The company manufactures, sells, imports, exports, trades in, an… Read more